Back to search
FDAFDA · Food and drugs·Recall number Z-0203-2024

Coapt Dome Electrode, Gen2 system, cutaneous electrode

Published November 8, 2023 · Recall initiated: October 2, 2023

Summary

FDA records medical device Class II recall Z-0203-2024, published November 8, 2023 and initiated October 2, 2023. Recalling firm: Coapt LLC; Status: Ongoing; Reported quantity: 247 devices; Lot: UDI/DI +B618E0/$+201907E00256B, all Gen2 system serial number. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Patient may experience minor burn or blistering if device is exposed to direct sunlight and/or warm temperatures for over 12 hours or battery is damaged.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Coapt LLC
Distributor
Worldwide distribution - US Nationwide and the country of Sweden.
Lot
UDI/DI +B618E0/$+201907E00256B, all Gen2 system serial number
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Coapt Dome Electrode, Gen2 system, cutaneous electrode recalled?

Yes. FDA published recall Z-0203-2024 on November 8, 2023. Reported hazard: Patient may experience minor burn or blistering if device is exposed to direct sunlight and/or warm temperatures for over 12 hours or battery is damaged.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail